(All fields required)
Please enter a valid email.
Please enter your name.
Research in the Pang lab focuses on the function of Fanconi anemia (FA) proteins in hematopoiesis. The process of FA disease progression in the context of hematopoiesis is characterized by bone marrow failure, clonal proliferation of hematopoietic stem and progenitor (HSC/P) cells, and progression to myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). The only curable treatment for this devastating disease is stem cell therapy through bone marrow transplantation. We are studying how the FA proteins function in HSC maintenance and how loss of the FA protein function promotes malignant evolution of HSC/P cells. We are also interested in exploring a novel concept of manipulating the interaction between stem cell and bone marrow microenvironment or niche as a way to improve FA hematopoietic stem cell transplantation.
Li X, Sipple J, Pang Q, and Du W. Salidroside stimulates DNA repair enzyme Parp-1 activity in HSC maintenance. Blood. 119, 4162-4173. 2012.
Du W, Rani R, Sipple J, Schick J, Myers KC, Mehta P, Andreassen PA, Davies SM, and Pang Q. The FA pathway counteracts oxidative stress through selective protection of antioxidant defense gene promoters. Blood. 119(18):4142-51. 2012.
Ali AM, Pradhan A, Singh TR, Du C, Li J, Wahengbam K, Grassman E, Auerbach AD, Pang Q, Meetei AR. FAAP20: a novel ubiquitin-binding FA nuclear core complex protein required for functional integrity of the FA-BRCA DNA repair pathway.Blood. 119(14):3285-94. 2012.
Li J, Sipple J, Maynard S, Mehta PA, Rose SR, Davies SM, Pang Q. Fanconi Anemia Links Reactive Oxygen Species to Insulin Resistance and Obesity.Antioxid Redox Signal. 17(8):1083-98. 2012.
Mehta PA, Svahn J, Davies SM, Pang Q, Harris R, Ghezzi P, Lanza T, Ferretti E, Barabino P, Mueller R, Dufour C. Etanercept treatment in Fanconi anaemia; combined US and Italian experience.Br J Haematol. 158(6):809-11. 2012.
Du, W. Li, J. Sipple, J. Chen, J. and Pang,Q. A cytoplasmic FANCA-FANCC complex interacts and stabilizes the leukemic NPMc protein. J Biol Chem. 285(48):37436-44. 2010.
Li J, Du W, Maynard S, Andreassen PR, and Pang, Q. Oxidative-stress specific interaction between FANCD2 and FOXO3a. Blood. 2010 Feb 25;115(8):1545-8. 2010.
Pang Q, Andreassen PR. Fanconi anemia proteins and endogenous stresses. Mutat. Res., 668:42-53. 2009.
Du W, Zhou Y, Pike S, and Pang, Q. NPM Phosphorylation Stimulates Cdk1, Overrides G2/M Checkpoint and Increases Leukemic Blasts in Mice. Carcinogenesis 31(2):302-10. 2009.
Rani R, Li J, Pang Q. Differential p53 engagement in response to oxidative and oncogenic stresses in Fanconi anemia mice. Cancer Res. 68(23):9693-702. 2008.
Zhou Y, Du W, Koretsky T, Bagby GC, Pang Q. TAT-mediated intracellular delivery of NPM-derived peptide induces apoptosis in leukemic cells and suppresses leukemogenesis in mice. Blood, 112(6):2474-83. 2008.
Zhang X, Shang X, Guo F, Kirby M, Murphy K, Kelly P, Reeves L, Williams DA, Smith FO, Zheng Y, Pang Q. Defective homing is associated with altered Cdc42 activity in cells from Fanconi anemia group A patients. Blood, 112(5):1683-6. 2008.
Du W, Adam Z, Rani R, Zhang X, Pang Q. Oxidative stress in Fanconi anemia hematopoiesis and disease progression. Antioxidants & Redox Signaling, 10(11):1909-21. 2008.
3333 Burnet Avenue, Cincinnati, Ohio 45229-3026 | 1-513-636-4200 | 1-800-344-2462 | TTY:1-513-636-4900
New to Cincinnati Children’s or live outside of the tri-state area? 1-877-881-8479
© 1999-2013 Cincinnati Children's Hospital Medical Center